Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
R-PRO Consulting AB
AB
Active
Org 5595033977
Warfvinges Väg 7, 112 18
Stockholm
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2024 · 1 year old
0 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
R-PRO Consulting AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2025: 2M
2M
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2025: 1M
1M
2025
Income statement
SEK thousands
Item
2025
Revenue
1 890
Staff expenses
−959
EBITDA
868
Depreciation & amort.
—
EBIT
868
Net financials
−1
Profit before tax
867
Tax
−185
Net profit
682
Balance sheet
SEK thousands
Item
2025
Total assets
1 187
Equity
707
Long-term debt
—
Short-term debt
481
Total debt
481
Financial ratios
5-year trend
EBITDA margin
45,9 %
This company
15,8 %
Market median
This company
Market median
191% above market
2025
2025
Equity ratio
59,5 %
This company
38,2 %
Market median
This company
Market median
56% above market
2025
2025
Return on equity
96,5 %
This company
18,4 %
Market median
This company
Market median
424% above market
2025
2025
Net profit margin
36,1 %
This company
8,1 %
Market median
This company
Market median
346% above market
2025
2025
Asset turnover
1,59×
This company
1,12×
Market median
This company
Market median
42% above market
2025
2025
Debt / equity
0,68×
This company
0,62×
Market median
This company
Market median
10% above market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-11-04 – 2025-12-31
View
PDF
More on R-PRO Consulting AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
